Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.
Industry, Sector and Symbol
Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Phone212-918-1800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$635.70 million
Profitability
Miscellaneous
Employees1,998
Next Earnings Date4/30/2019 (Confirmed)
OptionableOptionable
Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions
What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
How were Medidata Solutions' earnings last quarter?
Medidata Solutions Inc (NASDAQ:MDSO) posted its quarterly earnings results on Tuesday, February, 12th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.08. The company earned $167.19 million during the quarter, compared to analyst estimates of $168.08 million. Medidata Solutions had a net margin of 8.17% and a return on equity of 10.03%. Medidata Solutions's revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period last year, the firm posted $0.41 EPS. View Medidata Solutions' Earnings History.
When is Medidata Solutions' next earnings date?
What guidance has Medidata Solutions issued on next quarter's earnings?
Medidata Solutions updated its FY 2019 earnings guidance on Tuesday, February, 12th. The company provided earnings per share (EPS) guidance of $1.71-1.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.84. The company issued revenue guidance of $734-746 million, compared to the consensus revenue estimate of $749.49 million.
What price target have analysts set for MDSO?
14 equities research analysts have issued twelve-month target prices for Medidata Solutions' stock. Their forecasts range from $70.00 to $92.00. On average, they anticipate Medidata Solutions' stock price to reach $83.7807 in the next twelve months. This suggests that the stock has a possible downside of 6.7%. View Analyst Price Targets for Medidata Solutions.
What is the consensus analysts' recommendation for Medidata Solutions?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 1 sell rating, 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.
Has Medidata Solutions been receiving favorable news coverage?
News headlines about MDSO stock have trended somewhat negative on Wednesday, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Medidata Solutions earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the next several days.
Who are some of Medidata Solutions' key competitors?
Some companies that are related to Medidata Solutions include Splunk (SPLK), Veeva Systems (VEEV), Check Point Software Technologies (CHKP), CA (CA), Synopsys (SNPS), Cadence Design Systems (CDNS), SS&C Technologies (SSNC), Twilio (TWLO), ANSYS (ANSS), Symantec (SYMC), Citrix Systems (CTXS), PTC (PTC), Paycom Software (PAYC), Okta (OKTA) and Atlassian (TEAM).
What other stocks do shareholders of Medidata Solutions own?
Who are Medidata Solutions' key executives?
Medidata Solutions' management team includes the folowing people:
- Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
- Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
- Mr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 46)
- Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 48)
- Mr. Michael Pray, Exec. VP of Sales (Age 53)
Who are Medidata Solutions' major shareholders?
Medidata Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Global Thematic Partners LLC (1.58%), Conestoga Capital Advisors LLC (1.36%), Peregrine Capital Management LLC (0.48%), Summit Creek Advisors LLC (0.23%), Retirement Systems of Alabama (0.18%) and Malaga Cove Capital LLC (0.06%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.
Which institutional investors are selling Medidata Solutions stock?
MDSO stock was sold by a variety of institutional investors in the last quarter, including Global Thematic Partners LLC, Peregrine Capital Management LLC, Retirement Systems of Alabama, Foundry Partners LLC, Brinker Capital Inc., Strs Ohio, Summit Creek Advisors LLC and Malaga Cove Capital LLC. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.
Which institutional investors are buying Medidata Solutions stock?
MDSO stock was acquired by a variety of institutional investors in the last quarter, including Mercer Global Advisors Inc. ADV, Mercer Global Advisors Inc. ADV, Sciencast Management LP, Conestoga Capital Advisors LLC, Canton Hathaway LLC, Virtu Financial LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Medidata Solutions.
How do I buy shares of Medidata Solutions?
Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medidata Solutions' stock price today?
One share of MDSO stock can currently be purchased for approximately $89.80.
How big of a company is Medidata Solutions?
Medidata Solutions has a market capitalization of $5.59 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.
What is Medidata Solutions' official website?
How can I contact Medidata Solutions?
Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]
MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
